Chi Chiu Mok

14.3k total citations · 2 hit papers
228 papers, 8.3k citations indexed

About

Chi Chiu Mok is a scholar working on Rheumatology, Immunology and Nephrology. According to data from OpenAlex, Chi Chiu Mok has authored 228 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 183 papers in Rheumatology, 71 papers in Immunology and 38 papers in Nephrology. Recurrent topics in Chi Chiu Mok's work include Systemic Lupus Erythematosus Research (157 papers), Rheumatoid Arthritis Research and Therapies (39 papers) and Renal Diseases and Glomerulopathies (37 papers). Chi Chiu Mok is often cited by papers focused on Systemic Lupus Erythematosus Research (157 papers), Rheumatoid Arthritis Research and Therapies (39 papers) and Renal Diseases and Glomerulopathies (37 papers). Chi Chiu Mok collaborates with scholars based in China, United States and Hong Kong. Chi Chiu Mok's co-authors include Chi Hung To, Chak Sing Lau, Ling Yin Ho, Anselm Mak, Raymond Woon Sing Wong, Sau Mei Tse, Kar Li Chan, Woon Leung Ng, Wai‐Kwok Wong and Ka Lung Yu and has published in prestigious journals such as The Lancet, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Chi Chiu Mok

213 papers receiving 8.1k citations

Hit Papers

Pathogenesis of systemic lupus erythematosus 2003 2026 2010 2018 2003 2024 200 400 600

Peers

Chi Chiu Mok
Chi Chiu Mok
Citations per year, relative to Chi Chiu Mok Chi Chiu Mok (= 1×) peers Guillermo Ruiz‐Irastorza

Countries citing papers authored by Chi Chiu Mok

Since Specialization
Citations

This map shows the geographic impact of Chi Chiu Mok's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi Chiu Mok with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi Chiu Mok more than expected).

Fields of papers citing papers by Chi Chiu Mok

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi Chiu Mok. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi Chiu Mok. The network helps show where Chi Chiu Mok may publish in the future.

Co-authorship network of co-authors of Chi Chiu Mok

This figure shows the co-authorship network connecting the top 25 collaborators of Chi Chiu Mok. A scholar is included among the top collaborators of Chi Chiu Mok based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi Chiu Mok. Chi Chiu Mok is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Shuhui, Lakhansing Pardeshi, Chris Cheung, et al.. (2025). Systematic over-expression of secondary metabolism transcription factors to reveal the pharmaceutical potential of Aspergillus nidulans. Communications Biology. 8(1). 1444–1444. 1 indexed citations
2.
Mok, Chi Chiu, Ho So, Laniyati Hamijoyo, et al.. (2025). The 2024 APLAR Consensus on the Management of Lupus Nephritis. International Journal of Rheumatic Diseases. 28(1). e70021–e70021. 4 indexed citations
3.
Li, Yaxi, Kamala Vanarsa, Kyung Hyun Lee, et al.. (2024). Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis. Journal of Autoimmunity. 143. 103165–103165. 14 indexed citations
4.
Vanarsa, Kamala, Ting Zhang, Jack Hutcheson, et al.. (2024). iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus. Lupus Science & Medicine. 11(1). e000673–e000673. 1 indexed citations
5.
Mok, Chi Chiu, et al.. (2024). The Potential Use of Arsenic Trioxide in the Treatment of Systemic Lupus Erythematosus. International Journal of Molecular Sciences. 25(17). 9577–9577. 2 indexed citations
6.
Kasitanon, Nuntana, Laniyati Hamijoyo, Kenji Oku, et al.. (2022). Management of non‐renal manifestations of systemic lupus erythematosus: A systematic literature review for the APLAR consensus statements. International Journal of Rheumatic Diseases. 25(11). 1220–1229. 8 indexed citations
7.
Mok, Chi Chiu, Ling Yin Ho, Sau Mei Tse, Kar Li Chan, & Chi Hung To. (2022). Prevalence and risk factors of herpes zoster infection in patients with rheumatic diseases not receiving biologic or targeted therapies. Clinical Rheumatology. 42(4). 1019–1026. 11 indexed citations
8.
Vanarsa, Kamala, et al.. (2022). Exploring urine:serum fractional excretion ratios as potential biomarkers for lupus nephritis. Frontiers in Immunology. 13. 910993–910993. 10 indexed citations
9.
Mok, Chi Chiu, et al.. (2019). Management of Psychosis in Neuropsychiatric Lupus. SHILAP Revista de lepidopterología. 19(1). 9–17. 5 indexed citations
10.
Makinde, Hadijat M., Maria Gulinello, Kamala Vanarsa, et al.. (2018). Lipocalin-2 is a pathogenic determinant and biomarker of neuropsychiatric lupus. Journal of Autoimmunity. 96. 59–73. 45 indexed citations
11.
Mok, Chi Chiu, Chak Sing Lau, Lai‐Shan Tam, et al.. (2018). Clinical presentation, treatment and outcome of Takayasu’s arteritis in southern Chinese: a multicenter retrospective study. Rheumatology International. 38(12). 2263–2270. 7 indexed citations
12.
Mok, Chi Chiu. (2016). Towards new avenues in the management of lupus glomerulonephritis. Nature Reviews Rheumatology. 12(4). 221–234. 60 indexed citations
13.
Mok, Chi Chiu. (2016). Pro: The use of calcineurin inhibitors in the treatment of lupus nephritis. Nephrology Dialysis Transplantation. 31(10). 1561–1566. 17 indexed citations
14.
Mok, Chi Chiu. (2014). Emerging biological therapies for systemic lupus erythematosus. Expert Opinion on Emerging Drugs. 19(2). 303–322. 23 indexed citations
15.
Mok, Chi Chiu. (2013). Rituximab for the treatment of rheumatoid arthritis: an update. Drug Design Development and Therapy. 8. 87–87. 124 indexed citations
16.
Rovin, Brad H., Samir V. Parikh, Lee A. Hebert, et al.. (2012). Lupus Nephritis. Clinical Journal of the American Society of Nephrology. 8(1). 147–153. 37 indexed citations
17.
Mok, Chi Chiu, et al.. (2012). Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case–control study. Annals of the Rheumatic Diseases. 72(5). 659–664. 132 indexed citations
18.
Mok, Chi Chiu, et al.. (2010). Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus. Translational research. 156(6). 320–325. 41 indexed citations
19.
Mok, Chi Chiu, et al.. (2005). Long-term Survival of Southern Chinese Patients With Systemic Lupus Erythematosus. Medicine. 84(4). 218–224. 132 indexed citations
20.
Mok, Chi Chiu, Raymond Woon Sing Wong, & Chak Sing Lau. (1999). Ovarian failure and flares of systemic lupus erythematosus. Arthritis & Rheumatism. 42(6). 1274–1280. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026